BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18848664)

  • 1. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
    Evens N; Bosier B; Lavey BJ; Kozlowski JA; Vermaelen P; Baudemprez L; Busson R; Lambert DM; Van Laere K; Verbruggen AM; Bormans GM
    Nucl Med Biol; 2008 Oct; 35(7):793-800. PubMed ID: 18848664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
    Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
    Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
    Lunn CA; Fine JS; Rojas-Triana A; Jackson JV; Fan X; Kung TT; Gonsiorek W; Schwarz MA; Lavey B; Kozlowski JA; Narula SK; Lundell DJ; Hipkin RW; Bober LA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile and high-yield synthesis of N-(4-diethylamino)benzyl-4-[¹¹C]methoxy-N-(p-tolyl)benzenesulfonamide as a new potential PET selective CB2 radioligand.
    Gao M; Xu J; Wang M; Zheng QH
    Appl Radiat Isot; 2014 Aug; 90():181-6. PubMed ID: 24768996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8.
    Wang M; Cooley B; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
    Appl Radiat Isot; 2008 Oct; 66(10):1406-13. PubMed ID: 18455923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer.
    Wuest F; Kniess T; Henry B; Peeters BW; Wiegerinck PH; Pietzsch J; Bergmann R
    Appl Radiat Isot; 2009 Feb; 67(2):308-12. PubMed ID: 19071028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
    Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336.
    Gonsiorek W; Hesk D; Chen SC; Kinsley D; Fine JS; Jackson JV; Bober LA; Deno G; Bian H; Fossetta J; Lunn CA; Kozlowski JA; Lavey B; Piwinski J; Narula SK; Lundell DJ; Hipkin RW
    J Biol Chem; 2006 Sep; 281(38):28143-51. PubMed ID: 16754676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors.
    Moran MD; Wilson AA; Elmore CS; Parkes J; Ng A; Sadovski O; Graff A; Daskalakis ZJ; Houle S; Chapdelaine MJ; Vasdev N
    Bioorg Med Chem; 2012 Jul; 20(14):4482-8. PubMed ID: 22717238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.
    Kassiou M; Dannals RF; Liu X; Wong DF; Ravert HT; Scheffel UA
    Bioorg Med Chem; 2005 Jun; 13(11):3623-6. PubMed ID: 15862990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labeling of endothelin receptors with [(11)C]L-753,037: studies in mice and a dog.
    Aleksic S; Szabo Z; Scheffel U; Ravert HT; Mathews WB; Kerenyi L; Rauseo PA; Gibson RE; Burns HD; Dannals RF
    J Nucl Med; 2001 Aug; 42(8):1274-80. PubMed ID: 11483691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET.
    Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
    Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
    J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro.
    Samén E; Thorell JO; Fredriksson A; Stone-Elander S
    Nucl Med Biol; 2006 Nov; 33(8):1005-11. PubMed ID: 17127174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
    Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
    J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
    Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
    Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.